Skip to content
Hantavirus.Watcher
Menu
← Back to ledger
OutbreakPublished Jun 3 · 2026AI-classified · awaiting human verification

Four Cases of Hantavirus Infections Involving the Andes Strain Detected in Bolivia

Read original atvertexaisearch.cloud.google.com

Padcaya, Tarija, BoliviaConfidence 95%4 affectedToday

Four new laboratory-confirmed hantavirus infections of the Andes strain have been detected in Bolivia's Tarija region, prompting intensified surveillance in border zones.

Species mentioned

  • human

Source articles

Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.

  • Primary
    Four Cases of Hantavirus Infections Involving the Andes Strain Detected in Bolivia

    vertexaisearch.cloud.google.com · 2026-06-03

    Health authorities in Bolivia have intensified surveillance after four new laboratory-confirmed hantavirus infections were reported in the Tarija region, near the Argentina border. Cases were identified in the municipalities of Bermejo, Yacuiba, and Padcaya. The Andes strain, known for its human-to-human transmission capability, is a growing concern, especially in these border zones with constant movement between Bolivia and Argentina.

  • Reference
    Second hantavirus death in Tarija Department, Bolivia, linked to farming activities

    vertexaisearch.cloud.google.com · 2026-06-03

    The Departmental Health Service (Sedes) of Tarija, Bolivia, confirmed the second hantavirus-related death in 2026 on March 26, 2026. This fatality involved a 30-year-old male agricultural worker from Yacuiba who had incidental contact with wild rodents during fruit harvest activities. This follows the first death reported in the same area on February 13, 2026, involving a 36-year-old male. Nine suspected cases have been reported in Tarija to date in 2026, including two confirmed cases and seven ruled out. Endemic areas for hantavirus in Tarija Department include Yacuiba, Bermejo, and Padcaya

Reminder

This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.